Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma

Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma

The mechanisms of the hypercoagulable state in cirrhotics with and without hepatocellular carcinoma are incompetently comprehended. Objective: We aimed to explore the plasma Annexin A5/PS + MP ratio in these patients. Higher levels of Annexin A5 and PhosphatidylSerine bearing microparticles have bee...

Full description

Bibliographic Details
Main Authors: Waleed Mohamed Serag, Bedoor Shehap eldeen Mohammed, Magdy Mahmoud Mohamed, Basem Eysa Elsayed
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:Heliyon
Subjects:
Inflammation
Pathophysiology
Hematological system
Immunology
Laboratory medicine
Clinical research
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844020315218

Internet

http://www.sciencedirect.com/science/article/pii/S2405844020315218

Similar Items